On Monday, Glaukos Corporation (NYSE: GKOS) opened lower -3.34%% from the last session, before settling in for the closing price of $100.15. Price fluctuations for GKOS have ranged from $77.10 to $163.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 54.72% at the time writing. With a float of $54.99 million, this company’s outstanding shares have now reached $56.74 million.
Let’s look at the performance matrix of the company that is accounted for 995 employees. In terms of profitability, gross margin is 75.75%, operating margin of -25.09%, and the pretax margin is -30.4%.
Glaukos Corporation (GKOS) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Glaukos Corporation is 3.76%, while institutional ownership is 100.83%. The most recent insider transaction that took place on Mar 25 ’25, was worth 162,399. In this transaction SVP & CHIEF FINANCIAL OFFICER of this company sold 1,520 shares at a rate of $106.84, taking the stock ownership to the 53,431 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Officer proposed sale 1,520 for $106.84, making the entire transaction worth $162,402.
Glaukos Corporation (GKOS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 54.72% per share during the next fiscal year.
Glaukos Corporation (NYSE: GKOS) Trading Performance Indicators
Check out the current performance indicators for Glaukos Corporation (GKOS). In the past quarter, the stock posted a quick ratio of 5.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.31, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach 0.03 in one year’s time.
Technical Analysis of Glaukos Corporation (GKOS)
Glaukos Corporation (NYSE: GKOS) saw its 5-day average volume 1.14 million, a positive change from its year-to-date volume of 0.94 million. As of the previous 9 days, the stock’s Stochastic %D was 65.76%.
During the past 100 days, Glaukos Corporation’s (GKOS) raw stochastic average was set at 23.26%, which indicates a significant decrease from 48.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.67% in the past 14 days, which was lower than the 67.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $93.65, while its 200-day Moving Average is $122.74. Nevertheless, the first resistance level for the watch stands at $99.03 in the near term. At $101.25, the stock is likely to face the second major resistance level. The third major resistance level sits at $102.75. If the price goes on to break the first support level at $95.31, it is likely to go to the next support level at $93.81. Assuming the price breaks the second support level, the third support level stands at $91.59.
Glaukos Corporation (NYSE: GKOS) Key Stats
There are currently 57,141K shares outstanding in the company with a market cap of 5.53 billion. Presently, the company’s annual sales total 383,480 K according to its annual income of -146,370 K. Last quarter, the company’s sales amounted to 106,660 K and its income totaled -18,150 K.
